http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013045959-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90c28d8f8b81f377e2e7c76a5f3608d3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-015 |
| filingDate | 2012-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2897462c689cda500b26f9c4ae76489c |
| publicationDate | 2013-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2013045959-A2 |
| titleOfInvention | Camphene reduces plasma cholesterol and triglycerides |
| abstract | The present invention describes a pharmaceutical preparation comprising camphene and derivatives thereof which derivatives make camphene water soluble, said pharmaceutical preparation aiming at the decrease of LDL-cholesterol and triglycerides in a human or in an animal, wherein said camphene originates from Chios Mastic gum essential oil. The effectiveness of the said pharmaceutical preparation is dose dependent. |
| priorityDate | 2011-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 230.